{"entity":{"type":"insider","cik":"0001861519","url":"/insider/0001861519","json_url":"/insider/0001861519.json","name":"Stengone Carmine N.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":6,"first":"2024-09-12","last":"2026-08-03","span_basis":"filed_date"},"name_variants":[{"name":"Stengone Carmine N.","source":"filing","n_filings":6,"first_seen":"2024-09-12","last_seen":"2026-08-03"}],"transactions":[{"id":5848293,"accession":"0001628280-26-052031","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-052031","line_url":"/filing/0001628280-26-052031#line-2","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861519","owner_name":"Stengone Carmine N.","owner_display_name":"Stengone Carmine N.","owner_url":"/insider/0001861519","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":16.0116,"price_display":"16.01","price_state":"stated","total_value":40029.0,"total_display":"40,029.00","total_whole":"40,029","shares_owned_after":17217.0,"shares_owned_after_display":"17,217","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-03","filed_date":"2026-08-03","scope":"insider"},{"id":6173826,"accession":"0001628280-26-047710","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-047710","line_url":"/filing/0001628280-26-047710#line-2","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861519","owner_name":"Stengone Carmine N.","owner_display_name":"Stengone Carmine N.","owner_url":"/insider/0001861519","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":40000.0,"total_display":"40,000.00","total_whole":"40,000","shares_owned_after":17217.0,"shares_owned_after_display":"17,217","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-08","filed_date":"2026-07-08","scope":"insider"},{"id":5896721,"accession":"0001628280-26-046653","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-26-046653","line_url":"/filing/0001628280-26-046653#line-3","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861519","owner_name":"Stengone Carmine N.","owner_display_name":"Stengone Carmine N.","owner_url":"/insider/0001861519","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":16.008,"price_display":"16.01","price_state":"stated","total_value":160080.0,"total_display":"160,080.00","total_whole":"160,080","shares_owned_after":17217.0,"shares_owned_after_display":"17,217","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-30","filed_date":"2026-07-01","scope":"insider"},{"id":5812427,"accession":"0001437749-26-005892","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001437749-26-005892","line_url":"/filing/0001437749-26-005892#line-4","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861519","owner_name":"Stengone Carmine N.","owner_display_name":"Stengone Carmine N.","owner_url":"/insider/0001861519","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2700.0,"shares_display":"2,700","price_per_share":16.0155,"price_display":"16.02","price_state":"stated","total_value":43241.85,"total_display":"43,241.85","total_whole":"43,242","shares_owned_after":14954.0,"shares_owned_after_display":"14,954","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-25","filed_date":"2026-02-26","scope":"insider"},{"id":5812423,"accession":"0001437749-26-005892","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-26-005892","line_url":"/filing/0001437749-26-005892#line-2","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861519","owner_name":"Stengone Carmine N.","owner_display_name":"Stengone Carmine N.","owner_url":"/insider/0001861519","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4400.0,"shares_display":"4,400","price_per_share":16.0195,"price_display":"16.02","price_state":"stated","total_value":70485.8,"total_display":"70,485.80","total_whole":"70,486","shares_owned_after":14954.0,"shares_owned_after_display":"14,954","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-24","filed_date":"2026-02-26","scope":"insider"},{"id":5739835,"accession":"0001437749-26-004126","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-26-004126","line_url":"/filing/0001437749-26-004126#line-2","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861519","owner_name":"Stengone Carmine N.","owner_display_name":"Stengone Carmine N.","owner_url":"/insider/0001861519","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":6400.0,"total_display":"6,400.00","total_whole":"6,400","shares_owned_after":14954.0,"shares_owned_after_display":"14,954","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-11","filed_date":"2026-02-13","scope":"insider"},{"id":2702715,"accession":"0001372514-24-000115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001372514-24-000115","line_url":"/filing/0001372514-24-000115#line-1","is_derivative":false,"issuer_cik":"0001372514","issuer_name":"KIORA PHARMACEUTICALS INC","issuer_ticker":"KPRX","issuer_name_source":null,"issuer_url":"/issuer/0001372514","owner_cik":"0001861519","owner_name":"Stengone Carmine N.","owner_display_name":"Stengone Carmine N.","owner_url":"/insider/0001861519","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250.0,"shares_display":"1,250","price_per_share":3.68,"price_display":"3.68","price_state":"stated","total_value":4600.0,"total_display":"4,600.00","total_whole":"4,600","shares_owned_after":1250.0,"shares_owned_after_display":"1,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-11","filed_date":"2024-09-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001855175","name":"Contineum Therapeutics, Inc.","url":"/issuer/0001855175","role":"Director, Officer (CEO and President)","n_filings":5,"first_seen":"2026-02-13","last_seen":"2026-08-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001372514","name":"KIORA PHARMACEUTICALS INC","url":"/issuer/0001372514","role":"Director","n_filings":1,"first_seen":"2024-09-12","last_seen":"2024-09-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001861519","retrieved_at":"2026-08-26T06:06:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}